FDA Import Refusal AEK-9687383-9/10002/1 — Bajaj Healthcare Ltd
The FDA refused shipment AEK-9687383-9/10002/1 from Bajaj Healthcare Ltd (India) on Sep 3, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- Sep 3, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75